Sort   by:  
 Page size 
UnknownTreatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
Not available
S-EPMC5597253 | biostudies-literature
UnknownRituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
Not available
S-EPMC4872010 | biostudies-literature
UnknownThe common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.
Not available
S-EPMC2997744 | biostudies-literature
UnknownProlonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.
Not available
S-EPMC7724909 | biostudies-literature
Unknown4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.
Not available
S-EPMC7360146 | biostudies-literature
UnknownCorrection: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Not available
S-EPMC7109133 | biostudies-literature
UnknownQuality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Not available
S-EPMC6734915 | biostudies-literature
Unknown3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
Not available
S-EPMC5378224 | biostudies-literature
UnknownESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.
Not available
S-EPMC4176456 | biostudies-literature
UnknownOutcomes of anatomical versus functional testing for coronary artery disease.
Not available
S-EPMC4473773 | biostudies-literature
Sort   by:  
 Page size